Skip to main content

Table 2 Distribution of burden and specific comorbidities in the population from the Elixhauser index (2005–2016)

From: Impact of comorbidity on the short- and medium-term risk of revision in total hip and knee arthroplasty

  TKA (n = 49,701) THA (n = 17,923)
Primary Revision Primary Revision
n % n % n % n %
Burden of comorbidity
 0 comorbidities 14,548 29.3 528 3.6 6862 38.3 175 2.5
 1 comorbidity 17,479 35.2 585 3.3 6079 33.9 159 2.6
 > =2 comorbidities 17,674 35.6 531 3.0 4982 27.8 130 2.6
Uncomplicated hypertension 26,968 54.3 837 3.1 7972 44.5 209 2.6
Uncomplicated diabetes 7903 15.9 221 2.8 2223 12.4 63 2.8
Obesity 5383 10.8 180 3.3 1235 6.9 46 3.7
Depression 4735 9.5 159 3.4 1160 6.5 33 2.8
Chronic pulmonary disease 4100 8.3 117 2.9 1420 7.9 33 2.3
Hypothyroidism 2928 5.9 93 3.2 746 4.2 16 2.1
Deficiency anemia 1162 2.3 34 2.9 471 2.7 12 2.5
Renal failure 964 1.9 18 1.9 391 2.2 7 1.8
Hypertension with complications 949 1.9 18 1.9 305 1.7 2 0.6
Valvular disease 886 1.8 22 2.5 300 1.7 2 0.7
Rheumatoid arthritis /collagen vascular disease 680 1.4 19 2.8 288 1.6 7 2.4
Other neurological disorders 724 1.5 22 3.0 233 1.3 5 2.1
Liver disease 673 1.4 34 5.1 284 1.6 8 2.8
Congestive heart failure 489 1.0 8 1.6 158 0.9 2 1.2
Peripheral vascular disorders 368 0.7 11 3.0 166 0.9 7 4.2
Solid tumor 226 0.5 3 1.3 100 0.6 2 2.0
Diabetes with complications 227 0.5 13 5.7 64 0.4 NR NR
Coagulopathy 221 0.4 3 1.4 77 0.4 NR NR
Blood loss anemia 215 0.4 13 6.1 67 0.4 NR NR
Fluid and electrolyte disorders 214 0.4 5 2.3 126 0.7 2 1.6
Alcohol abuse 194 0.4 6 3.1 132 0.7 3 2.2
Psychosis 172 0.4 3 1.7 77 0.4 5 6.5
Paralysis 88 0.2 7 8.0 39 0.2 2 5.1
Pulmonary circulation disorders 75 0.2 2 2.7 20 0.1 NR NR
Lymphoma 38 0.1 1 2.6 16 0.1 1 5.9
Peptic ulcer disease (excluding bleeding) 31 0.1 2 6.5 8 < 0.1 NR NR
Drug abuse 12 < 0.1 NR NR 28 0.2 NR NR
Metastatic cancer 10 < 0.1 NR NR 10 0.1 1 10.0
Weight loss 10 < 0.1 1 10.0 9 0.1 NR NR
AIDS 4 < 0.1 NR NR 16 0.1 1 5.9
  1. THA Total Hip Arthroplasty, TKA Total Knee Arthroplasty
  2. n: total number of patients in primary or revision THA or TKA during the study period (2005–2016)
  3. %: percentage of patients